Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Alkyl Amines Chemicals Limited (ALKYLAMINE.NS)
INR1,900.70
+32.60 (+1.75%)
IN NSE Basic Materials Chemicals - Specialty
Address
401-407, Nirman Vyapar Kendra 400703
Navi Mumbai, IN
Navi Mumbai, IN
CEO
Yogesh Mathradas Kothari
Website
alkylamines.com
IPO
2007-11-26
ISIN INE150B01039
Also trades on
Bombay Stock Exchange · ALKYLAMINE.BO (INR)
National Stock Exchange of India · ALKYLAMINE.NS (INR)
Description
Alkyl Amines Chemicals Limited functions as a global producer and purveyor of a diverse portfolio of chemical substances, encompassing various amines, their derivatives, and a selection of specialized chemicals. The company's offerings include aliphatic amines such as methylamines, ethylamines, and isopropylamines, alongside numerous amine derivatives like dimethylamine hydrochloride and 3-ethoxy propylamine. Additionally, it provides unique chemical compounds, including acetonitrile and 2-aminoethoxy ethanol. Its clientele spans multiple industries, prominently including the pharmaceutical, agrochemical, water treatment, and rubber chemical sectors. Established in 1979, the company's main office is situated in Navi Mumbai, India.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
INR1,900.70
+32.60 (+1.75%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
223.9K
Beta
0.27
Float Shares
13.90M
Free Float %
27.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.23% | -8.99% | +14.13% | +3.56% | -11.07% | -0.22% | -7.30% | -37.32% | -59.26% | +1,184.15% | +23,564.19% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1,900.70
DCF (Unlevered)
1,366.60
-28.1%
DCF (Levered)
1,907.66
+0.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
33% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Quality scores
Altman Z-Score
15.68
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%-2.3% Q1'26: +0.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-3.2% Q1'26: -1.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+8.8% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+13.9% ★ Q1'26: +13.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+12.3% ★ Q1'26: +12.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.1% ★ Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.00× ★ Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 2 Rev. Ana. 3 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 3 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.76B
est: 4.90B (-2.7%)
|
4.84B
est: 4.81B (+0.6%)
|
5.01B
est: 5.13B (-2.4%)
|
6.16B
est: 5.75B (+7.2%)
|
8.46B
est: 8.39B (+0.9%)
|
9.93B
est: 10.07B (-1.4%)
|
12.42B
est: 11.75B (+5.8%)
|
15.42B
est: 15.38B (+0.2%)
|
16.83B
est: 16.77B (+0.4%)
|
14.41B
est: 14.24B (+1.2%)
|
15.72B
est: 16.19B (-2.9%)
|
15.67B
15.25B – 16.08B
-3.3% YoY
|
17.76B
17.76B – 17.76B
+13.4% YoY
|
20.25B
20.25B – 20.25B
+14.0% YoY
|
25.61B
25.61B – 25.61B
+26.5% YoY
|
| EBITDA |
882.06M
est: 1.11B (-20.3%)
|
954.97M
est: 1.09B (-12.1%)
|
941.24M
est: 1.16B (-18.8%)
|
1.18B
est: 1.30B (-8.9%)
|
1.65B
est: 1.52B (+8.3%)
|
2.58B
est: 1.71B (+50.6%)
|
4.30B
est: 3.28B (+31.0%)
|
3.26B
est: 3.86B (-15.4%)
|
3.48B
est: 4.66B (-25.3%)
|
2.54B
est: 5.41B (-53.0%)
|
2.97B
est: 3.14B (-5.5%)
|
3.04B
2.96B – 3.12B
-3.3% YoY
|
3.44B
3.44B – 3.44B
+13.4% YoY
|
3.93B
3.93B – 3.93B
+14.0% YoY
|
4.96B
4.96B – 4.96B
+26.5% YoY
|
| EBIT |
768.87M
est: 953.26M (-19.3%)
|
826.23M
est: 935.96M (-11.7%)
|
812.67M
est: 997.92M (-18.6%)
|
1.03B
est: 1.12B (-8.0%)
|
1.42B
est: 1.47B (-3.9%)
|
2.32B
est: 1.74B (+33.1%)
|
4.01B
est: 2.55B (+57.1%)
|
2.92B
est: 3.01B (-2.8%)
|
3.04B
est: 3.63B (-16.3%)
|
1.96B
est: 4.21B (-53.3%)
|
2.26B
est: 2.56B (-11.4%)
|
2.47B
2.41B – 2.54B
-3.3% YoY
|
2.80B
2.80B – 2.80B
+13.4% YoY
|
3.20B
3.20B – 3.20B
+14.0% YoY
|
4.04B
4.04B – 4.04B
+26.5% YoY
|
| Net Income |
451.35M
est: 459.31M (-1.7%)
|
500.38M
est: 468.94M (+6.7%)
|
518.18M
est: 542.86M (-4.5%)
|
660.00M
est: 718.76M (-8.2%)
|
861.04M
est: 944.59M (-8.8%)
|
2.15B
est: 1.03B (+108.3%)
|
2.95B
est: 2.39B (+23.6%)
|
2.25B
est: 2.81B (-20.0%)
|
2.29B
est: 3.39B (-32.6%)
|
1.49B
est: 3.94B (-62.2%)
|
1.86B
est: 4.78B (-61.1%)
|
1.81B
1.71B – 1.86B
-62.2% YoY
|
1.88B
1.88B – 1.88B
+4.4% YoY
|
2.29B
1.49B – 3.16B
+21.7% YoY
|
3.78B
3.78B – 3.78B
+65.0% YoY
|
| SGA |
315.24M
est: 315.92M (-0.2%)
|
360.30M
est: 310.18M (+16.2%)
|
374.48M
est: 330.72M (+13.2%)
|
426.10M
est: 370.65M (+15.0%)
|
535.42M
est: 1.08B (-50.5%)
|
701.11M
est: 1.33B (-47.1%)
|
929.65M
est: 772.88M (+20.3%)
|
883.33M
est: 909.55M (-2.9%)
|
977.49M
est: 1.10B (-11.0%)
|
954.25M
est: 1.27B (-25.1%)
|
1.04B
est: 1.48B (-29.8%)
|
1.43B
1.39B – 1.47B
-3.3% YoY
|
1.62B
1.62B – 1.62B
+13.4% YoY
|
1.85B
1.85B – 1.85B
+14.0% YoY
|
2.34B
2.34B – 2.34B
+26.5% YoY
|
| EPS |
8.85
est: 8.97 (-1.4%)
|
9.81
est: 9.16 (+7.1%)
|
10.16
est: 10.60 (-4.2%)
|
12.94
est: 14.04 (-7.8%)
|
16.89
est: 17.60 (-4.0%)
|
42.22
est: 35.85 (+17.8%)
|
57.90
est: 53.86 (+7.5%)
|
44.04
est: 47.07 (-6.4%)
|
44.75
est: 49.13 (-8.9%)
|
29.13
est: 31.88 (-8.6%)
|
36.40
est: 38.43 (-5.3%)
|
35.30
33.42 – 36.34
-8.2% YoY
|
36.85
36.85 – 36.85
+4.4% YoY
|
44.85
29.08 – 61.80
+21.7% YoY
|
74.00
74.00 – 74.00
+65.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
183.32M
OE per share TTM
3.58
Owner's Yield
0.20%
Maintenance CapEx ratio
7.38%
Maint CapEx / Avg PPE
62.5%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 9 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 70.6K | 0.26% |
| 2 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 31.3K | 0.48% |
| 3 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 5.6K | 0.22% |
| 4 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 16.9K | 0.22% |
| 5 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 9.1K | 0.22% |
| 6 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 4.0K | 0.22% |
| 7 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 461.30 | 0.22% |
| 8 | Vanguard Retirement Income ETF Portfolio VRIF.TO | 0.00% | 151.58 | 0.31% |
| 9 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 72.19 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
3.08M
Shares Outstanding
51.14M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yogesh Mathradas Kothari | Chairman & MD | 145M | male |
| Suneet Yogesh Kothari | Executive Director | 58M | male |
| Kirat Patel | Executive Director | 58M | male |
| Rakesh S. Goyal | Whole-time Director - Operations | 21M | male |
| Chintamani Dattatraya Thatte | GM of Legal, Company Secretary & Compliance Officer | 3M | male |
| Ramchandra N. Iyer | Vice President of Manufacturing | — | male |
| Prasanna Somalwar | General Manager of Research & Development & Business Development | — | — |
| Udipt Agarwal | Chief Commercial Officer | — | male |
| Kanchan A. Shinde | Chief Financial Officer | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ALKYLAMINE.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
